Snap Labs Ammonia Inhalants Inhalant
Product Images NDC 87270-001

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Snap Labs Ammonia Inhalants (NDC 87270-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Brined Llc D/b/a Snap Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Drug_facts_image (Drug Facts Label Snap Labs)

Drug_facts_image (Drug Facts Label   Snap Labs)
Drug Facts panel for Snap Labs Ammonia Inhalants 150 mg/mL nasal inhalant. It lists active ingredient ammonia (15%), its purpose as an inhalant, uses to help prevent or treat fainting, warnings against use in breathing problems or asthma, directions to hold the inhalant away from the face and crush between thumb and finger before use, and inactive ingredients such as alcohol USP and various oils. Distributor information for Brined LLC d/b/a Snap Labs is included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.